Literature DB >> 205414

A novel type of endotoxin structure present in Bordetella pertussis. Isolation of two different polysaccharides bound to lipid A.

A Le Dur, M Caroff, R Chaby, L Szabó.   

Abstract

The endotoxin of Bordetella pertussis was cleaved by mild acidic hydrolysis to yield a polysaccharide (polysaccharide I, 15%), a glycolipid (63%) and lipid X (2%). Further treatment of the glycolipid with stronger acid released a second polysaccharide (polysaccharide II, 9%) and material similar to lipid A present in enterobacterial endotoxins. Both polysaccharides possess a single molecule of 3-deoxy-2-octulosonic acid as the reducing, terminal sugar. In polysaccharide II the octulosonic acid is phosphorylated in position 5 and presumably substituted in position 4; in polysaccharide I the octulosonic acid is not phosphorylated, but is substituted in position 5. Following treatment of the endotoxin with strong base, a fragment was isolated that contained bound, non-phosphorylated 3-deoxy-2-octulosonic acid, glucosamine phosphate and fatty acids. This indicated that polysaccharide I, like polysaccharide II, was bound to the lipid region of the endotoxin. The endotoxin structure thus defined is different from that proposed for the lipopolysaccharides of enterobacteria.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 205414     DOI: 10.1111/j.1432-1033.1978.tb12201.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis.

Authors:  D Martin; M S Peppler; B R Brodeur
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.

Authors:  Z M Li; J L Cowell; M J Brennan; D L Burns; C R Manclark
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

3.  Production and characterization of monoclonal antibodies directed against Bordetella pertussis lipopolysaccharide.

Authors:  B Gustafsson; U Lindquist; M Andersson
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

4.  Inhibition of lipopolysaccharide mitogenicity with characterized anti-lipid A monoclonal antibodies.

Authors:  R Girard; R Chaby
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

Review 5.  Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.

Authors:  B R Brodeur; D Martin; J Hamel; R D Shahin; C Laferrière
Journal:  Springer Semin Immunopathol       Date:  1993

6.  Bordetella pertussis waaA encodes a monofunctional 2-keto-3-deoxy-D-manno-octulosonic acid transferase that can complement an Escherichia coli waaA mutation.

Authors:  T Isobe; K A White; A G Allen; M Peacock; C R Raetz; D J Maskell
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

7.  Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis.

Authors:  B Trollfors; T Lagergård; J Taranger; E Bergfors; R Schneerson; J B Robbins
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

8.  Structure of the terminal reducing heptasaccharide of polysaccharide 1 isolated from the Bordetella pertussis endotoxin.

Authors:  M Moreau; R Chaby; L Szabo
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

9.  Glucosamine found as a substituent of both phosphate groups in Bordetella lipid A backbones: role of a BvgAS-activated ArnT ortholog.

Authors:  Nico Marr; Alina Tirsoaga; Didier Blanot; Rachel Fernandez; Martine Caroff
Journal:  J Bacteriol       Date:  2008-04-18       Impact factor: 3.490

10.  Isolation of two protein-free and chemically different lipopolysaccharides from Bordetella pertussis phenol-extracted endotoxin.

Authors:  A Le Dur; R Chaby; L Szabó
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.